Meeting
2023 ASCO Annual Meeting
Effect of astragalus polysaccharides (PG2) treatment of adjuvant chemotherapy-induced fatigue in premenopausal patients with breast cancer.
Authors
KUN MING RAU
E-Da Cancer Hospital, Kaohsiung, Taiwan
KUN MING RAU , Wen-Chi Shen , Shin-Cheh Chen , Cheng-Hsu Wang , Ruey Kuen Hsieh , Chao-Ming Hung Sr., Mengting Peng , Chien-Ting Liu Sr., Yuehshih Chang , Wen-Ling Kuo , Hsu-Huan Chou , Kun-Yun Yeh , Tsung-Han Wu , Chun-Feng Wu , Chang Pei-Hung , Yen-Min Huang , Chi-Chang Yu , Chun-Hui Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
NCT03314805
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 537)
DOI
10.1200/JCO.2023.41.16_suppl.537
Abstract #
537
Poster Bd #
367
Abstract Disclosures
Similar Posters
First Author: Begoña Bermejo
Poster
2021 ASCO Annual Meeting
ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.
First Author: Toon Van Gorp
Poster
2020 ASCO Virtual Scientific Program
Differential effects of epirubicin and docetaxel on the immune system in patients with breast cancer (BC).
First Author: Kerstin Wimmer
Poster
2019 ASCO Annual Meeting
The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
First Author: Sara Bravaccini